Bétamaze,
Combactam,
CP 45899,
CP-45899,
CP45899,
Penicillanic Acid Sulfone,
Sodium, Sulbactam,
Sulbactam,
Sulbactam Sodium,
Sulfone, Penicillanic Acid,
SULBACTAM,
68373-14-8,
sulbactam acid,
Penicillanic Acid Sulfone,
Betamaze,
Sulbactamum,
(2S,5R)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide,
penicillanic acid 1,1-dioxide,
UNII-S4TF6I2330,
CP 45899,
MFCD00867005,
CHEMBL403,
CHEBI:9321,
S4TF6I2330,
Sulbactam;Penicillanic acid sulfone,
(2S,5R)-3,3-Dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid 4,4-dioxide,
Sulbactam [INN:BAN],
CP-45,899,
Sulbactamum [INN-Latin],
DSSTox_CID_3605,
(2S,5R)-3,3-dimethyl-4,4,7-trioxo-4$l^{6}-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid,
DSSTox_RID_77104,
DSSTox_GSID_23605,
2,2-dimethyl-1,1-dioxidopenam-3alpha-carboxylic acid,
EINECS 269-878-2,
CP-45899,
SMR000387064,
Sulbactam free acid,
CAS-68373-14-8,
SR-01000760610,
C8H11NO5S,
Penicillanic acid dioxide,
(2S,5R)-3,3-Dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptan-2-carbonsaeure 4,4-dioxid,
Sulbactam,(S),
Sulbactam (INN),
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-, 4,4-dioxide, (2S-cis)-,
CP45899,
Sulbactam acid (base),
NCGC00159487-06,
Sulbactam; Sulbactam Acid,
SCHEMBL47781,
MLS001048859,
MLS001304017,
Penicillanic acid S,S-dioxide,
Sodium 1,1-Dioxypenicillanate,
AC1L2X62,
DTXSID1023605,
CTK2F3300,
FKENQMMABCRJMK-RITPCOANSA-N,
HMS2090E07,
HMS2269A12,
HMS3651C06,
HMS3715B09,
ZINC897244,
BCP13271,
EX-A2000,
HY-B0334,
KS-00000XO5,
Tox21_113642,
ANW-43630,
BBL033518,
BDBM50021954,
s1958,
STK801889,
AKOS004119988,
Tox21_113642_1,
CCG-221124,
CS-2376,
DB09324,
KS-5198,
MCULE-8384465258,
Sulbactam, analytical reference material,
NCGC00159336-02,
NCGC00159336-03,
NCGC00159336-05,
AC-18973,
AN-14929,
SC-12203,
AB0014047,
AB2000391,
FT-0630775,
S0868,
ST24049316,
A-2179,
C07770,
D08533,
AB00698109-06,
AB00698109-08,
AB00698109_09,
373S148,
A836122,
SR-01000760610-2,
SR-01000760610-3,
BRD-K44133266-001-10-0,
Z1563146038,
Sulbactam, European Pharmacopoeia (EP) Reference Standard,
Sulbactam, United States Pharmacopeia (USP) Reference Standard,
(2S,5R)-2-Carboxylato-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane4,4-dioxide,
(2S,5R)-3,3-Dimethyl-4,4,7-trioxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid,
3,3-Dimethyl-4,4,7-trioxo-4lambda*6*-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid,
Sulbactam for peak identification, European Pharmacopoeia (EP) Reference Standard,
((2S-cis)-3,3-Dimethyl-7-oxo-4-thia-1-azabicyclo[3,2,0]heptane-2-carboxylic acid 4,4-dioxide ),
(2S,5R)-3,3-dimethyl-4,4,7-trioxo-4?^{6}-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid,
(2S,5R)-3,3-Dimethyl-4,4,7-trioxo-4lambda*6*-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid,
(2S,5R)-3,3-dimethyl-4,4,7-trioxo-4lambda-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid,
(2S,5R)-3,3-dimethyl-4,4,7-trioxo-4lambda6-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid,
(2S,5R)-3,3-dimethyl-4,4,7-tris(oxidanylidene)-4$l^{6}-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid,
(2S,5R)?-?3,3-?dimethyl-?7-?oxo-?4-?thia-?1-?azabicyclo[3.2.0]?heptane-?2-?carboxylic acid 4,4-dioxide,
(S)-3,3-Dimethyl-7-(R)-oxo-4,4-dioxo-4lambda*6*-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid,
0RN,
3,3-Dimethyl-4,4,7-trioxo-4lambda*6*-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid (Sulbactam),
4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-,4,4-dioxide, (2S, cis),
4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid, 3,3-dimethyl-7-oxo-, 4,4-dioxide, (2S,5R)-,
null,
Combactam,
Unasyn,
SULBACTAM SODIUM,
Sodium, Sulbactam,
D0S4SX,
Sulfone, Penicillanic Acid,
C8-H11-N-O5-S,
CID130313,
K134,
1718A,
B2131,
K-134,
(2S,5R)-3,3-dimethyl-4,4,7-trioxo-4,
D013407,
Sulbactam, 98%, an irreversible beta-lactamase inhibitor - 1G 1g,
(2S,5R)-3,3-dimethyl-7-oxo-4,4-dioxide-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid,
4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-, 4,4-dioxide, (2S,5R)-,
69388-84-7,